Literature DB >> 32718970

Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections.

Nimish Patel1,2, Nicholas Stornelli3, Ryan J Sangiovanni2,4, David B Huang5, Thomas P Lodise6,3.   

Abstract

Among hospitalized adults who received vancomycin for their skin and skin structure infection (SSSI), patients who experienced acute kidney injury (AKI) had considerably higher 30-day readmission rates. Nearly half of the observed 30-day readmissions were due to non-SSSI-related reasons, which is consistent with the persistent organ dysfunction observed among patients with AKI.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  AKI; outcomes; readmissions; vancomycin

Mesh：

Substances：

Year:  2020        PMID： 32718970      PMCID： PMC7508587          DOI： 10.1128/AAC.01268-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

3.  Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients.

Authors:  Emi Minejima; Joyce Choi; Paul Beringer; Mimi Lou; Edmund Tse; Annie Wong-Beringer
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.

Authors:  Shelley S Magill; Jonathan R Edwards; Zintars G Beldavs; Ghinwa Dumyati; Sarah J Janelle; Marion A Kainer; Ruth Lynfield; Joelle Nadle; Melinda M Neuhauser; Susan M Ray; Katherine Richards; Richard Rodriguez; Deborah L Thompson; Scott K Fridkin
Journal:  JAMA       Date:  2014-10-08       Impact factor: 56.272

5.  Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

Authors:  Ravina Kullar; Susan L Davis; Donald P Levine; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

6.  30-Day Readmissions After an Acute Kidney Injury Hospitalization.

Authors:  Samuel A Silver; Ziv Harel; Eric McArthur; Danielle M Nash; Rey Acedillo; Abhijat Kitchlu; Amit X Garg; Glenn M Chertow; Chaim M Bell; Ron Wald
Journal:  Am J Med       Date:  2016-10-14       Impact factor: 4.965

Review 7.  Delayed Consequences of Acute Kidney Injury.

Authors:  Sharidan K Parr; Edward D Siew
Journal:  Adv Chronic Kidney Dis       Date:  2016-05       Impact factor: 3.620

Review 8.  Distant Organ Dysfunction in Acute Kidney Injury: A Review.

Authors:  Sul A Lee; Martina Cozzi; Errol L Bush; Hamid Rabb
Journal:  Am J Kidney Dis       Date:  2018-06-14       Impact factor: 8.860

Review 9.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

Review 10.  Acute kidney injury: short-term and long-term effects.

Authors:  James F Doyle; Lui G Forni
Journal:  Crit Care       Date:  2016-07-04       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.